Listed

Sutro Biopharma, Inc.

STRONasdaqCIK 1382101HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$9.8m, Q2 FY2026
Operating income−$29.9m, Q2 FY2026
Net income−$38.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m16.9Revenue, Q3 FY2023, three months to 2023-09-30$16.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure114Revenue, Q4 FY2023, three months to 2023-12-31$113.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0000950170-25-038884. Derived: 12-month figure less the 9-month figure.Report this figure13.0Revenue, Q1 FY2024, three months to 2024-03-31$13.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure25.7Revenue, Q2 FY2024, three months to 2024-06-30$25.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure8.5Revenue, Q3 FY2024, three months to 2024-09-30$8.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure14.8Revenue, Q4 FY2024, three months to 2024-12-31$14.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure17.4Revenue, Q1 FY2025, three months to 2025-03-31$17.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure63.7Revenue, Q2 FY2025, three months to 2025-06-30$63.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure9.7Revenue, Q3 FY2025, three months to 2025-09-30$9.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure11.6Revenue, Q4 FY2025, three months to 2025-12-31$11.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure14.5Revenue, Q1 FY2026, three months to 2026-03-31$14.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure9.8Revenue, Q2 FY2026, three months to 2026-06-30$9.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Research and development$m45.7Research and development, Q3 FY2023, three months to 2023-09-30$45.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure53.8Research and development, Q4 FY2023, three months to 2023-12-31$53.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0000950170-25-038884. Derived: 12-month figure less the 9-month figure.Report this figure56.9Research and development, Q1 FY2024, three months to 2024-03-31$56.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure62.0Research and development, Q2 FY2024, three months to 2024-06-30$62.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure62.1Research and development, Q3 FY2024, three months to 2024-09-30$62.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure71.0Research and development, Q4 FY2024, three months to 2024-12-31$71.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure51.6Research and development, Q1 FY2025, three months to 2025-03-31$51.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure38.3Research and development, Q2 FY2025, three months to 2025-06-30$38.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure39.9Research and development, Q3 FY2025, three months to 2025-09-30$39.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure36.6Research and development, Q4 FY2025, three months to 2025-12-31$36.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure36.6Research and development, Q1 FY2026, three months to 2026-03-31$36.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure31.7Research and development, Q2 FY2026, three months to 2026-06-30$31.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Operating income$m(44.0)Operating income, Q3 FY2023, three months to 2023-09-30−$44.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure43.2Operating income, Q4 FY2023, three months to 2023-12-31$43.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038884. Derived: 12-month figure less the 9-month figure.Report this figure(56.6)Operating income, Q1 FY2024, three months to 2024-03-31−$56.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure(48.7)Operating income, Q2 FY2024, three months to 2024-06-30−$48.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure(67.9)Operating income, Q3 FY2024, three months to 2024-09-30−$67.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(65.3)Operating income, Q4 FY2024, three months to 2024-12-31−$65.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure(68.5)Operating income, Q1 FY2025, three months to 2025-03-31−$68.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(3.3)Operating income, Q2 FY2025, three months to 2025-06-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(48.5)Operating income, Q3 FY2025, three months to 2025-09-30−$48.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(38.0)Operating income, Q4 FY2025, three months to 2025-12-31−$38.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure(29.7)Operating income, Q1 FY2026, three months to 2026-03-31−$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(29.9)Operating income, Q2 FY2026, three months to 2026-06-30−$29.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m1.8Income tax, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure15.8Income tax, Q4 FY2023, three months to 2023-12-31$15.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-13, accession 0000950170-25-038884. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2024, three months to 2024-06-30$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure2.4Income tax, Q4 FY2024, three months to 2024-12-31$2.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(0.0)Income tax, Q2 FY2025, three months to 2025-06-30−$18.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(0.1)Income tax, Q4 FY2025, three months to 2025-12-31−$82.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2026, three months to 2026-03-31−$15.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Net income$m(49.3)Net income, Q3 FY2023, three months to 2023-09-30−$49.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure31.1Net income, Q4 FY2023, three months to 2023-12-31$31.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038884. Derived: 12-month figure less the 9-month figure.Report this figure(58.2)Net income, Q1 FY2024, three months to 2024-03-31−$58.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(48.0)Net income, Q2 FY2024, three months to 2024-06-30−$48.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(48.8)Net income, Q3 FY2024, three months to 2024-09-30−$48.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(72.4)Net income, Q4 FY2024, three months to 2024-12-31−$72.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure(76.0)Net income, Q1 FY2025, three months to 2025-03-31−$76.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(11.5)Net income, Q2 FY2025, three months to 2025-06-30−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(56.9)Net income, Q3 FY2025, three months to 2025-09-30−$56.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(46.8)Net income, Q4 FY2025, three months to 2025-12-31−$46.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure(38.5)Net income, Q1 FY2026, three months to 2026-03-31−$38.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(38.5)Net income, Q2 FY2026, three months to 2026-06-30−$38.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Diluted EPS$ per share(0.81)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figurenot reported(0.59)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure(0.59)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure(0.59)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figurenot reported(9.08)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$9.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(1.35)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(0.67)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figurenot reported(2.94)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(2.33)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$2.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Basic EPS$ per share(0.81)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figurenot reported(0.59)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure(0.59)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure(0.59)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figurenot reported(9.08)Basic EPS, Q1 FY2025, three months to 2025-03-31−$9.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(1.35)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(0.67)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figurenot reported(2.94)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(2.33)Basic EPS, Q2 FY2026, three months to 2026-06-30−$2.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure

Balance sheet

Cash and equivalents$54.3m, Q2 FY2026
Long-term debt$0, FY2023
Shareholders' equity−$103.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m81.8Cash and equivalents, Q3 FY2023, at 2023-09-30$81.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure69.3Cash and equivalents, FY2023, at 2023-12-31$69.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0000950170-25-038884.Report this figure65.2Cash and equivalents, Q1 FY2024, at 2024-03-31$65.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure90.8Cash and equivalents, Q2 FY2024, at 2024-06-30$90.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure175Cash and equivalents, Q3 FY2024, at 2024-09-30$174.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure190Cash and equivalents, FY2024, at 2024-12-31$190.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001193125-26-119873.Report this figure106Cash and equivalents, Q1 FY2025, at 2025-03-31$106.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure64.0Cash and equivalents, Q2 FY2025, at 2025-06-30$64.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure65.9Cash and equivalents, Q3 FY2025, at 2025-09-30$65.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure58.1Cash and equivalents, FY2025, at 2025-12-31$58.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure73.7Cash and equivalents, Q1 FY2026, at 2026-03-31$73.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure54.3Cash and equivalents, Q2 FY2026, at 2026-06-30$54.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Current assets$m381Current assets, Q3 FY2023, at 2023-09-30$381.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-063037.Report this figure422Current assets, FY2023, at 2023-12-31$421.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038884.Report this figure355Current assets, Q1 FY2024, at 2024-03-31$354.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058718.Report this figure443Current assets, Q2 FY2024, at 2024-06-30$443.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096336.Report this figure406Current assets, Q3 FY2024, at 2024-09-30$405.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure343Current assets, FY2024, at 2024-12-31$343.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001193125-26-119873.Report this figure287Current assets, Q1 FY2025, at 2025-03-31$287.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure232Current assets, Q2 FY2025, at 2025-06-30$231.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure182Current assets, Q3 FY2025, at 2025-09-30$182.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure151Current assets, FY2025, at 2025-12-31$150.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure221Current assets, Q1 FY2026, at 2026-03-31$221.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure176Current assets, Q2 FY2026, at 2026-06-30$175.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Total assets$m432Total assets, Q3 FY2023, at 2023-09-30$431.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0000950170-23-063037.Report this figure471Total assets, FY2023, at 2023-12-31$470.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0000950170-25-038884.Report this figure403Total assets, Q1 FY2024, at 2024-03-31$403.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058718.Report this figure489Total assets, Q2 FY2024, at 2024-06-30$489.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096336.Report this figure452Total assets, Q3 FY2024, at 2024-09-30$451.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure387Total assets, FY2024, at 2024-12-31$387.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001193125-26-119873.Report this figure321Total assets, Q1 FY2025, at 2025-03-31$321.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure262Total assets, Q2 FY2025, at 2025-06-30$262.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure210Total assets, Q3 FY2025, at 2025-09-30$209.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure174Total assets, FY2025, at 2025-12-31$173.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure242Total assets, Q1 FY2026, at 2026-03-31$242.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure194Total assets, Q2 FY2026, at 2026-06-30$194.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Current liabilities$m73.6Current liabilities, Q3 FY2023, at 2023-09-30$73.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-063037.Report this figure93.7Current liabilities, FY2023, at 2023-12-31$93.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038884.Report this figure79.5Current liabilities, Q1 FY2024, at 2024-03-31$79.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058718.Report this figure130Current liabilities, Q2 FY2024, at 2024-06-30$130.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096336.Report this figure131Current liabilities, Q3 FY2024, at 2024-09-30$131.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure132Current liabilities, FY2024, at 2024-12-31$131.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001193125-26-119873.Report this figure133Current liabilities, Q1 FY2025, at 2025-03-31$133.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure74.2Current liabilities, Q2 FY2025, at 2025-06-30$74.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure71.9Current liabilities, Q3 FY2025, at 2025-09-30$71.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure75.1Current liabilities, FY2025, at 2025-12-31$75.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure70.8Current liabilities, Q1 FY2026, at 2026-03-31$70.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure52.9Current liabilities, Q2 FY2026, at 2026-06-30$52.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Total liabilities$m319Total liabilities, Q3 FY2023, at 2023-09-30$319.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0000950170-23-063037.Report this figure321Total liabilities, FY2023, at 2023-12-31$321.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0000950170-25-038884.Report this figure305Total liabilities, Q1 FY2024, at 2024-03-31$305.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058718.Report this figure337Total liabilities, Q2 FY2024, at 2024-06-30$336.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096336.Report this figure341Total liabilities, Q3 FY2024, at 2024-09-30$340.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure343Total liabilities, FY2024, at 2024-12-31$342.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001193125-26-119873.Report this figure347Total liabilities, Q1 FY2025, at 2025-03-31$347.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure294Total liabilities, Q2 FY2025, at 2025-06-30$294.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure297Total liabilities, Q3 FY2025, at 2025-09-30$296.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure306Total liabilities, FY2025, at 2025-12-31$306.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure309Total liabilities, Q1 FY2026, at 2026-03-31$308.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure298Total liabilities, Q2 FY2026, at 2026-06-30$297.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure
Long-term debt$mnot reported0.0Long-term debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2024-03-25, accession 0000950170-24-035949.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$m7.1Current portion of debt, Q3 FY2023, at 2023-09-30$7.1m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2023-11-13, accession 0000950170-23-063037.Report this figure4.1Current portion of debt, FY2023, at 2023-12-31$4.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2024-03-25, accession 0000950170-24-035949.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m112Shareholders' equity, Q3 FY2023, at 2023-09-30$112.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure150Shareholders' equity, FY2023, at 2023-12-31$149.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001193125-26-119873.Report this figure98.0Shareholders' equity, Q1 FY2024, at 2024-03-31$98.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure152Shareholders' equity, Q2 FY2024, at 2024-06-30$152.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure111Shareholders' equity, Q3 FY2024, at 2024-09-30$111.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure44.6Shareholders' equity, FY2024, at 2024-12-31$44.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(25.8)Shareholders' equity, Q1 FY2025, at 2025-03-31−$25.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(32.1)Shareholders' equity, Q2 FY2025, at 2025-06-30−$32.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(87.3)Shareholders' equity, Q3 FY2025, at 2025-09-30−$87.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure(132)Shareholders' equity, FY2025, at 2025-12-31−$132.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(66.9)Shareholders' equity, Q1 FY2026, at 2026-03-31−$66.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure(103)Shareholders' equity, Q2 FY2026, at 2026-06-30−$103.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure

Cash flow

Operating cash flow−$38.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(33.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$33.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-126407. Derived: 9-month figure less the 6-month figure.Report this figure14.1Operating cash flow, Q4 FY2023, three months to 2023-12-31$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0000950170-25-038884. Derived: 12-month figure less the 9-month figure.Report this figure(64.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$64.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure9.5Operating cash flow, Q2 FY2024, three months to 2024-06-30$9.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105219. Derived: 6-month figure less the 3-month figure.Report this figure(64.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$64.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-270036. Derived: 9-month figure less the 6-month figure.Report this figure(71.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$71.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure(67.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$67.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(44.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$44.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345748. Derived: 6-month figure less the 3-month figure.Report this figure(38.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$38.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-270036. Derived: 9-month figure less the 6-month figure.Report this figure(26.4)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$26.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001193125-26-119873. Derived: 12-month figure less the 9-month figure.Report this figure(42.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$42.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure(38.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$38.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001193125-26-345748. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)16.57m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares52.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3052,345,732 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0000950170-23-063037.Report this figure58.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3158,723,432 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058718.Report this figure60.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3060,339,475 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096336.Report this figure60.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3060,599,025 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-126407.Report this figure61.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3161,457,793 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-067072.Report this figure81.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3081,224,628 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105219.Report this figure82.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3082,043,671 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure8.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,364,294 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure8.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,511,985 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure84.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3084,869,864 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-270036.Report this figure13.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3113,082,355 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001193125-26-224170.Report this figure16.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3016,571,602 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure

Shares outstanding: 16.58mShares outstanding, period not labelled, at 2026-08-0716,581,171 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001193125-26-345748.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.